# Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

> clinical trial · VERIFIED · 2026-07-09

Status: RECRUITING · Sponsor: mylife Diabetes Care AG · Condition: Diabetes Type 1

- Company: mylife Diabetes Care AG
- Sector: Diabetes Type 1
- Primary source: https://clinicaltrials.gov/study/NCT07048795

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.